deflazacort oral suspension

Generic: deflazacort

Labeler: zydus pharmaceuticals (usa) inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deflazacort oral suspension
Generic Name deflazacort
Labeler zydus pharmaceuticals (usa) inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

deflazacort 22.75 mg/mL

Manufacturer
Zydus Pharmaceuticals (USA) Inc.

Identifiers & Regulatory

Product NDC 70710-2007
Product ID 70710-2007_a3fd06db-9b81-4d16-a166-0e8b6bb2eccd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA220042
Listing Expiration 2026-12-31
Marketing Start 2025-10-23

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707102007
Hyphenated Format 70710-2007

Supplemental Identifiers

RxCUI
1870964
UPC
0370710200732
UNII
KR5YZ6AE4B
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deflazacort oral suspension (source: ndc)
Generic Name deflazacort (source: ndc)
Application Number ANDA220042 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 22.75 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (70710-2007-3) / 13 mL in 1 BOTTLE
source: ndc

Packages (1)

70710-2007-3 1 BOTTLE in 1 CARTON (70710-2007-3) / 13 mL in 1 BOTTLE

Ingredients (1)

deflazacort (22.75 mg/mL)

Linked Drug Pages (1)

Deflazacort Oral Suspension ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a3fd06db-9b81-4d16-a166-0e8b6bb2eccd", "openfda": {"nui": ["N0000175576", "N0000175450"], "upc": ["0370710200732"], "unii": ["KR5YZ6AE4B"], "rxcui": ["1870964"], "spl_set_id": ["14569f71-573e-49fd-b80e-b3b52531b1c8"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70710-2007-3)  / 13 mL in 1 BOTTLE", "package_ndc": "70710-2007-3", "marketing_start_date": "20251023"}], "brand_name": "Deflazacort Oral Suspension", "product_id": "70710-2007_a3fd06db-9b81-4d16-a166-0e8b6bb2eccd", "dosage_form": "SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "70710-2007", "generic_name": "Deflazacort", "labeler_name": "Zydus Pharmaceuticals (USA) Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deflazacort Oral Suspension", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "22.75 mg/mL"}], "application_number": "ANDA220042", "marketing_category": "ANDA", "marketing_start_date": "20251023", "listing_expiration_date": "20261231"}